Quantinno Capital Management LP Grows Stake in Transcat, Inc. $TRNS

Quantinno Capital Management LP lifted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 184.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,548 shares of the scientific and technical instruments company’s stock after acquiring an additional 9,434 shares during the period. Quantinno Capital Management LP owned 0.16% of Transcat worth $1,069,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in TRNS. Rice Hall James & Associates LLC boosted its holdings in Transcat by 9.5% in the first quarter. Rice Hall James & Associates LLC now owns 38,870 shares of the scientific and technical instruments company’s stock valued at $2,855,000 after purchasing an additional 3,368 shares in the last quarter. Punch & Associates Investment Management Inc. raised its holdings in Transcat by 9.4% during the first quarter. Punch & Associates Investment Management Inc. now owns 64,775 shares of the scientific and technical instruments company’s stock worth $4,758,000 after purchasing an additional 5,540 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock worth $19,244,000 after buying an additional 9,266 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its position in shares of Transcat by 9.5% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 38,108 shares of the scientific and technical instruments company’s stock worth $2,799,000 after buying an additional 3,319 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of Transcat by 6,267.8% in the 1st quarter. Fifth Third Bancorp now owns 47,886 shares of the scientific and technical instruments company’s stock valued at $3,517,000 after buying an additional 47,134 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on TRNS. Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Northland Securities cut shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a research report on Wednesday, August 5th. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Finally, Wall Street Zen raised Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $105.50.

Insider Buying and Selling at Transcat

In other Transcat news, Director Christopher P. Gillette sold 504 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director owned 200 shares in the company, valued at approximately $18,846. This represents a 71.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig D. Cairns acquired 1,050 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were purchased at an average price of $93.97 per share, with a total value of $98,668.50. Following the transaction, the director owned 1,480 shares in the company, valued at $139,075.60. The trade was a 244.19% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by company insiders.

Transcat Stock Performance

Shares of Transcat stock opened at $93.70 on Friday. The firm’s fifty day simple moving average is $90.05 and its 200-day simple moving average is $80.70. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $100.00. The stock has a market capitalization of $877.03 million, a price-to-earnings ratio of 253.24 and a beta of 0.68. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.49 and a quick ratio of 2.11.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. As a group, equities analysts forecast that Transcat, Inc. will post 1.74 earnings per share for the current year.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.